← Leaderboards
Katy Patras
University Of Kentucky
$3,395,851
Attributed
$3,617,581
Total exposure
4
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $3.7M · FY2021–25$5M$3.8M$2.5M$1.3M$0
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$13,654,207 · 5
By mechanism
U19$10,036,626 · 1
R01$2,277,552 · 1
R21$1,340,029 · 3
Top collaborators
- Robert A Britton5 shared
- Katherine Paige Lemon5 shared
- Anthony W Maresso5 shared
- Konstantin V Korotkov2 shared
Most similar at University Of Kentucky
Same institution · by research overlap
- Konstantin V Korotkov$3,335,048
- Natalia Korotkova$5,800,967
Others in their field
Other Emerging Leaders on “Microbiota”
- Thomas Denny · Duke University$19,381,749
- Gary Fanger · Rise Therapeutics, Llc$14,374,725
- Zhiyong Yang · Fzata, Inc.$10,020,300
- Chun-Jun Guo · Weill Medical Coll Of Cornell Univ$9,235,746
- Dong Wang · Harvard School Of Public Health$8,709,110
- Ansel Hsiao · University Of California Riverside$7,358,776
Research focus
MicrobiotaComplexPathogenPreventEnvironmentInfectionAntibioticsInnovationMicrobialMicrobiomeMicrobial CommunityCessation Of LifeAntimicrobialVaginaVaginal MicrobiotaIn VitroPathway InteractionsMouse ModelCellsImmune ResponseIn VivoGenitourinary SystemBiologicalLife
Grant awards (16)
Microbiome Discovery and Mechanisms to Combat Antibiotic Resistance at Mucosal Surfaces$2,479,201
U19 · FY2025 · AI
Contribution of immune modulation, metabolism, and microbiota to Group B Streptococcal urinary tract infection$433,277
R01 · FY2025 · DK · contact PI
Microbiome Discovery and Mechanisms to Combat Antibiotic Resistance at Mucosal Surfaces$2,497,111
U19 · FY2024 · AI
Contribution of immune modulation, metabolism, and microbiota to Group B Streptococcal urinary tract infection$415,946
R01 · FY2024 · DK · contact PI
Evaluating the impact of human milk oligosaccharides on the vaginal microenvironment$234,670
R21 · FY2024 · HD · contact PI
The impact of gestational diabetes on Group B Streptococcal virulence and host immune response$198,614
R21 · FY2024 · AI · contact PI
Function of the type 7 secretion system in Group B Streptococcus$195,543
R21 · FY2024 · AI
Microbiome Discovery and Mechanisms to Combat Antibiotic Resistance at Mucosal Surfaces$119,807
U19 · FY2024 · AI
Microbiome Discovery and Mechanisms to Combat Antibiotic Resistance at Mucosal Surfaces$2,537,842
U19 · FY2023 · AI
Contribution of immune modulation, metabolism, and microbiota to Group B Streptococcal urinary tract infection$477,354
R01 · FY2023 · DK · contact PI
The impact of gestational diabetes on Group B Streptococcal virulence and host immune response$253,614
R21 · FY2023 · AI · contact PI
Function of the type 7 secretion system in Group B Streptococcus$247,918
R21 · FY2023 · AI
Evaluating the impact of human milk oligosaccharides on the vaginal microenvironment$209,670
R21 · FY2023 · HD · contact PI
Microbiome Discovery and Mechanisms to Combat Antibiotic Resistance at Mucosal Surfaces$2,402,665
U19 · FY2022 · AI
Contribution of immune modulation, metabolism, and microbiota to Group B Streptococcal urinary tract infection$505,026
R01 · FY2022 · DK · contact PI
Contribution of immune modulation, metabolism, and microbiota to Group B Streptococcal urinary tract infection$445,949
R01 · FY2021 · DK · contact PI